1.
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
by Fonner, Virginia A
AIDS (London), 2016, Vol.30 (12), p.1973-1983
2.
Impact of the 2016 tuberculosis guideline on a single paediatric tb centre in the uk
by Turnbull, L
Thorax, 2017, Vol.72 (12)
3.
Rescuing the bottom billion through control of neglected tropical diseases
by Hotez, Peter J, Prof
The Lancet (British edition), 2009, Vol.373 (9674), p.1570-1575
4.
Curcumin Suppresses Proliferation and Migration and Induces Apoptosis on Human Placental Choriocarcinoma Cells via ERK1/2 and SAPK/JNK MAPK Signaling Pathways1
by Lim, Whasun
Biology of reproduction, 2016, Vol.95 (4)
5.
Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria
by Mitchell, Kate M
AIDS (London), 2015, Vol.29 (15), p.2035-2044
6.
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
by Solomon, Marc M
AIDS (London), 2014, Vol.28 (6), p.851-859
7.
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial
by KAMYA, Moses R
AIDS (London), 2014, Vol.28 (18), p.2701-2709
8.
Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment
by Chikara, Shireen
Cancer letters, 2018, Vol.413, p.122-134
9.
Sexually transmitted infections: challenges ahead
by Unemo, Magnus
The Lancet infectious diseases, 2017, Vol.17 (8), p.e235-e279
10.
Repurposing metformin for the prevention of cancer and cancer recurrence
by Heckman-Stoddard, Brandy M
Diabetologia, 2017, Vol.60 (9), p.1639-1647
11.
Curcumin Suppresses Proliferation and Migration and Induces Apoptosis on Human Placental Choriocarcinoma Cells via ERK1/2 and SAPK/JNK MAPK Signaling Pathways
by Lim, Whasun
Biology of reproduction, 2016, Vol.95 (4), p.83-83
12.
Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor
by Flanagan, Meghan R
Annals of surgical oncology, 2019, Vol.26 (7), p.2127-2135
13.
Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?
by Stefanini, Bernardo
Expert review of anticancer therapy, 2022, Vol.ahead-of-print (ahead-of-print), p.1-3
14.
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
by Eckman, Mark H
The American heart journal, 2016, Vol.176, p.17-27
15.
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised...
by Higurashi, Takuma, MD
The lancet oncology, 2016, Vol.17 (4), p.475-483
16.
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs
by Wang, J.-F
European journal of clinical microbiology & infectious diseases, 2014, Vol.34 (4), p.651-659
17.
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
by Burn, John, Prof Sir
The Lancet (British edition), 2011, Vol.378 (9809), p.2081-2087
18.
Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs
by Mukandavire, Christinah
AIDS (London), 2017, Vol.31 (8), p.1181-1190
19.
Aflatoxin B 1 in poultry: Toxicology, metabolism and prevention
by Rawal, Sumit
Research in veterinary science, 2010, Vol.89 (3), p.325-331
20.
Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York
by KESSLER, Jason
AIDS (London), 2014, Vol.28 (18), p.2683-2691
